Grand Pharmaceutical Group Limited (HKG:0512)
Hong Kong · Delayed Price · Currency is HKD 5.24
+0.02 (0.38%)
May 29, 2026, 4:08 PM HKT
HKG:0512 Revenue
In the year 2025, Grand Pharmaceutical Group had annual revenue of 12.28B HKD with 5.48% growth. Grand Pharmaceutical Group had revenue of 6.18B in the half year ending December 31, 2025, with 36.03% growth.
Revenue
12.28B
Revenue Growth
+5.48%
P/S Ratio
1.49
Revenue / Employee
973.78K
Employees
12,614
Market Cap
18.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.28B | 638.38M | 5.48% |
| Dec 31, 2024 | 11.64B | 1.12B | 10.59% |
| Dec 31, 2023 | 10.53B | 967.31M | 10.12% |
| Dec 31, 2022 | 9.56B | 964.31M | 11.22% |
| Dec 31, 2021 | 8.60B | 2.25B | 35.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Revenue RankingsGrand Pharmaceutical Group News
- 2 months ago - Grand Pharmaceutical Group Earnings release: H2 2025 - Filings
- 10 months ago - Grand Pharmaceutical Group Quarterly report: H1 2025 - Filings
- 10 months ago - Grand Pharmaceutical Group Earnings release: H1 2025 - Filings